Question explored with the scientific record
Started from a private conversation ↓
Did Gates’s foundation or companies earn royalties from COVID vaccines?
The evidence block contains nothing about Gates foundation royalties from COVID vaccines.
The retrieved records cover vaccine potency assays [1], rotavirus shedding [2], monkeypox conspiracy theories on social media [3], and vaccine impact modeling [4]. None of them name Bill Gates, his foundation, any royalty payment, or any licensing agreement tied to COVID-19 vaccines. The question asks for a specific financial arrangement. The evidence does not contain a single document, disclosure, or audit that would confirm or deny such payments.
Without a record that names the foundation's licensing terms, equity stakes, or royalty streams from COVID-19 vaccine manufacturers, any answer would be speculation. The hypothesis is reasonable — public tax filings and licensing databases could in principle answer it — but the searches that produced this evidence block did not retrieve any such documents. I cannot cite a figure or arrangement that is not in the records.
My call: the retrieved evidence is empty on this question. Confidence: not clear — not because the answer is unknowable, but because the evidence provided does not contain it.
Sources examined 19
-
How can the public health impact of vaccination be estimated?
This paper describes and evaluates a suite of methods used by the Vaccine Impact Modelling Consortium (VIMC) to estimate the public health impact of vaccination, including calendar year, birth year, year-of-vaccination (YoV) methods and an impact extrapolation (IE) approach, dem…
DOI: 10.1186/s12889-021-12040-9 -
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies
A perspective on developing functionally relevant potency assays for monovalent and multivalent vaccines across evolving technologies, emphasizing the need for selective antibodies, in vitro–in vivo correlations, and global analytical capabilities across platforms including mRNA…
DOI: 10.1038/s41541-022-00470-4 -
Multivalent Rotavirus Vaccine and Wild-type Rotavirus Strain Shedding in Australian Infants: A Birth Cohort Study
This study investigates the prevalence and duration of rotavirus vaccine shedding in a community-based birth cohort of Australian infants, finding that a significant proportion shed the vaccine strain post-vaccination, with implications for interpreting diagnostic tests and moni…
DOI: 10.1093/cid/cix1022 -
Using Data From a Short Video Social Media Platform to Identify Emergent Monkeypox Conspiracy Theories
This study analyzes English-language short-video platform content to identify, categorize, and quantify emergent monkeypox conspiracy theories, assessing their reach and engagement to inform real-time public health surveillance.
DOI: 10.1001/jamanetworkopen.2022.36993 -
Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy
Profit from technological innovation depends on protection strength, access to complementary assets, and the emergence of a dominant design, guiding firms to choose between integration and licensing and shaping policy.
DOI: 10.1016/0048-7333(86)90027-2 -
Genetic engineering industry has growing pains
A 1981 News Feature analyzes the rapid growth and growing pains of the genetic engineering industry, including the emergence of a secondary information/supply network, patent and licensing hurdles (notably the Cohen–Boyer patent), workforce shortages, and regulatory consideratio…
DOI: 10.1021/cen-v059n014.p017 -
LICENSING AGRICULTURAL INTELLECTUAL PROPERTY: HOW SHOULD PUBLIC R&D INSTITUTIONS IN DEVELOPING COUNTRIES RESPOND?
Policy-oriented analysis arguing that public R&D institutions in developing countries should tailor licensing and MTAs for agricultural biotechnology to balance access, development, and public interests, illustrated by case studies (Golden Rice, papaya, PhilRice, AGERI) and reco…
DOI: 10.1142/S0219877012500289 -
Analysis of Copyright Implementation in Getty Images and Stability AI as a Case Study of Generative AI
A qualitative legal analysis of the Getty Images vs. Stability AI case, examining whether training AI on copyrighted images constitutes fair use or infringement, the concept of derivative works, and potential licensing frameworks to balance creator rights with AI innovation.
DOI: 10.47191/ijsshr/v8-i9-49 -
To patent or not to patent: challenges and solutions to the patent ban on new genomic techniques plant in EU
A policy-focused analysis arguing that a blanket patent ban on EU-regulated plants developed with new genomic techniques is likely ineffective, and proposing practical alternatives within the patent framework—such as a patent-clearing platform, compulsory licensing, and a labeli…
DOI: 10.1080/21645698.2025.2548638 -
Recent Technological and Intellectual Property Trends in Antibody–Drug Conjugate Research
A comprehensive review of recent technological and intellectual property trends in antibody-drug conjugate (ADC) research, covering ADC components (antibodies, linkers, payloads), conjugation methods, market dynamics, clinical approvals, and the evolving IP landscape with forwar…
DOI: 10.3390/pharmaceutics16020221 -
Inefficiencies in markets for intellectual property rights: experiences of academic and public research institutions
IPR markets in UK academic and public research institutions show pervasive inefficiencies in information, valuation, and price formation, with governance forms failing to capture full economic value and suggesting open dissemination may be more beneficial than privatization.
DOI: 10.1080/08109028.2012.671285 -
Corruption risks in COVID-19 vaccine deployment: lessons learned for future pandemic preparedness
A descriptive qualitative study triangulating literature and 16 key informant interviews identifies corruption risks in international COVID-19 vaccine procurement and deployment—highlighting transparency gaps, price/contract opacities, theft/diversion, and limited ACTA mechanism…
DOI: 10.1186/s12992-025-01096-6 -
Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review
A rapid review synthesizing factors that increase corruption risk in health procurement during the COVID-19 pandemic and evaluating anticorruption, transparency and accountability (ACTA) mechanisms to mitigate these risks, based on 20 academic articles and 17 grey literature sou…
DOI: 10.1186/s12992-023-00994-x -
Regional Disparities in Covid-19 Vaccine Distribution: A Global Analysis of Manufacturer Contributions and Product Availability
Regional vaccine deployment patterns reveal significant disparities across WHO regions and underscore the growing role of regional manufacturing and diversified suppliers in global COVID-19 vaccine access.
DOI: 10.63475/yjm.v4i1.0095 -
Verplichte Overheidszaken Principle on the Perspective of Covid-19 Vaccination in Indonesia
A normative juridical analysis examining the Verplichte Overheidszaken principle and state responsibility in Indonesia's COVID-19 vaccination policy, arguing that vaccination is a mandated public health obligation funded and implemented by the government.
DOI: 10.62795/fjl.v1i1.4 -
COVID-19 and Malaria Vaccine Advanced Market Commitments: Opportunities to Incentivize Investment in Africa’s Vaccine Manufacturing Industry
Vaccine manufacturing in Africa is currently limited and costly, but could become viable through coordinated regional policy, improved procurement, and innovative financing that build 2–3 regional hubs to meet rising immunization demand.
DOI: 10.54111/0001/uuu1 -
Lessons from Yemen: Diphtheria and Polio Campaign in the Context of COVID-19
Providing PPE and risk communication enabled resumed immunization campaigns in Yemen during COVID-19, achieving 75% diphtheria coverage (1,091,590/1,453,912 targeted) and 96% polio coverage (about 1.2 million under-fives) with modest PPE costs.
DOI: 10.5539/gjhs.v12n12p141 -
CORRUPTION DURING THE COVID-19 CRISIS RESPONSE IN UGANDA AND ITS IMPLICATIONS FOR THE RIGHT TO HEALTH
This study examines the pervasive corruption during Uganda's COVID-19 crisis response, highlighting its detrimental effects on health outcomes and the right to health despite existing legal frameworks.
DOI: 10.14426/jacl.v5i1.1266 -
Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
Using an age-structured SARS-CoV-2 transmission model calibrated to French hospital data, the study evaluates different Vaxzevria distribution strategies during May–September 2021 and finds that vaccinating those 55 and older yields a favorable balance of COVID-19 deaths averted…
DOI: 10.2807/1560-7917.es.2021.26.26.2100533